Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients

External validation of a Cox prognostic model: principles and methods

(2013) Patrick Royston et al.   BMC Medical Research Methodology

Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis

(2013) Sichuan Xi et al.   JOURNAL OF CLINICAL INVESTIGATION

The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis

(2012) Leonidas Benetatos et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

A Panel of Four miRNAs Accurately Differentiates Malignant from Benign Indeterminate Thyroid Lesions on Fine Needle Aspiration

(2012) X. M. Keutgen et al.   CLINICAL CANCER RESEARCH

GALNT9 Gene Expression Is a Prognostic Marker in Neuroblastoma Patients

(2012) N. Berois et al.   CLINICAL CHEMISTRY

Small regulatory RNAs controlled by genomic imprinting and their contribution to human disease

(2012) Michael Girardot et al.   Epigenetics

The dark side of a success story: microRNAs of the C19MC cluster in human tumours

(2012) Inga Flor et al.   JOURNAL OF PATHOLOGY

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification

(2012) L. J. Valentijn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma

(2011) C-H Gattolliat et al.   BRITISH JOURNAL OF CANCER

miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples

(2011) K. De Preter et al.   CLINICAL CANCER RESEARCH

A Multilocus Technique for Risk Evaluation of Patients with Neuroblastoma

(2011) I. M. Ambros et al.   CLINICAL CANCER RESEARCH

microRNA Signature and Expression of Dicer and Drosha Can Predict Prognosis and Delineate Risk Groups in Neuroblastoma

(2010) R.-J. Lin et al.   CANCER RESEARCH

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

(2010) K. De Preter et al.   CLINICAL CANCER RESEARCH

The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta

(2010) M. Noguer-Dance et al.   HUMAN MOLECULAR GENETICS

Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma

(2010) André Oberthuer et al.   JOURNAL OF CLINICAL ONCOLOGY

Recent Advances in Neuroblastoma

(2010) John M. Maris   NEW ENGLAND JOURNAL OF MEDICINE

Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma

(2010) Johannes H. Schulte et al.   NUCLEIC ACIDS RESEARCH

The Two Stem Cell MicroRNA Gene Clusters C19MC and miR-371-3 Are Activated by Specific Chromosomal Rearrangements in a Subgroup of Thyroid Adenomas

(2010) Volkhard Rippe et al.   PLoS One

The role of complex genomic alterations in neuroblastoma risk estimation

(2010) Matthias Fischer et al.   Genome Medicine

Frequent Amplification of a chr19q13.41 MicroRNA Polycistron in Aggressive Primitive Neuroectodermal Brain Tumors

(2009) Meihua Li et al.   CANCER CELL

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma

(2009) Isabelle Janoueix-Lerosey et al.   JOURNAL OF CLINICAL ONCOLOGY

C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts

(2009) M.-L. Bortolin-Cavaille et al.   NUCLEIC ACIDS RESEARCH

Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival

(2009) Isabella Bray et al.   PLoS One

The estimation of average hazard ratios by weighted Cox regression

(2009) Michael Schemper et al.   STATISTICS IN MEDICINE

MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S

(2008) Jean Bénard et al.   Molecular Oncology